The invention relates to processes for the preparation of polymorphic forms of (R)-(-)- tamsulosin. More particularly, it relates to the preparation of polymorphic forms of (R)-(-)- tamsulosin designated as Form I and II. The invention also relates to pharmaceutical compositions that include the Form I and Form II and use of the compositions for treating signs and symptoms of benign prostrate hyperplasia.
